The resignation of Steven F. Mayer, executive president of Grifols, has provoked a negative response among investors. The group's shares fell about 8% after the start of the session on Tuesday. The output was communicated yesterday afternoon, with the market already closed.
Mayer steps aside after just four months at the helm of the Grifols family group. His appointment was especially significant since he meant putting someone outside the family in charge for the first time.
The fall in shares has broken the trend of recovery in the value of titles, which had risen by more than 15% in the last month. The company is far from the pre-pandemic highs, from which time it accumulates a 60% drop, to the 13.25 euros at which it currently fluctuates.
To try to turn around the business and the figures, hit in 2021 and 2022 by the pandemic and the drop in plasma donations in the US, its main market, just a week ago it announced an adjustment and efficiency plan for which will leave 2,300 workers, a hundred of them in Spain. Grifols has recovered pre-covid revenue, with 4,351 million up to September, but profits are 30% lower, with 188 million euros.
Mayer's place will be occupied by Thomas Glanzmann, a manager of Swiss origin who until now was vice president of the firm.
